Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
PUT
Fluor
FLR
$7.96B
| $536K | ﹤0.01% |
44,400
-31,600
| -42% | -$332K |
|
|
TVRD
3252
Tvardi Therapeutics
TVRD
$23.4M
| $536K | ﹤0.01% |
871
+418
| +92% | +$231K |
|
3253
Monarch Casino & Resort
MCRI
$2.23B
| $535K | ﹤0.01% |
15,714
+1,024
| +7% | +$33.9K |
|
3254
AnaptysBio
ANAB
$1.68B
| $534K | ﹤0.01% |
23,892
-154,379
| -87% | -$2.82M |
|
3255
Preferred Bank
PFBC
$1.25B
| $534K | ﹤0.01% |
12,456
+1,268
| +11% | +$46.6K |
|
3256
NCR Voyix
VYX
$1.14B
| $534K | ﹤0.01% |
50,183
+5,448
| +12% | +$62.4K |
|
3257
Galicia Financial Group
GGAL
$7.42B
| $531K | ﹤0.01% |
54,766
-24,847
| -31% | -$212K |
|
3258
Scorpio Tankers
STNG
$3.81B
| $531K | ﹤0.01% |
41,446
+24,952
| +151% | +$452K |
|
3259
CALL
Sprouts Farmers Market
SFM
$8.01B
| $530K | ﹤0.01% |
20,700
-43,800
| -68% | -$1M |
|
3260
Anavex Life Sciences
AVXL
$310M
| $529K | ﹤0.01% |
107,585
+39,931
| +59% | +$151K |
|
3261
Applied Optoelectronics
AAOI
$11.5B
| $527K | ﹤0.01% |
48,465
+4,278
| +10% | +$39.2K |
|
|
SRDX
3262
DELISTED
Surmodics
SRDX
| $527K | ﹤0.01% |
12,183
+1,050
| +9% | +$39.7K |
|
|
EIGR
3263
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $527K | ﹤0.01% |
1,832
+1,236
| +207% | +$364K |
|
3264
First Busey Corp
BUSE
$2.56B
| $526K | ﹤0.01% |
28,200
+11,141
| +65% | +$193K |
|
|
PTR
3265
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $526K | ﹤0.01% |
15,913
+3,823
| +32% | +$135K |
|
3266
Arbor Realty Trust
ABR
$998M
| $525K | ﹤0.01% |
56,784
+56,674
| +51,522% | +$436K |
|
3267
PUT
British American Tobacco
BTI
$128B
| $524K | ﹤0.01% |
13,500
-23,300
| -63% | -$893K |
|
|
GOOS
3268
Canada Goose Holdings
GOOS
$856M
| $524K | ﹤0.01% |
22,625
+5,039
| +29% | +$112K |
|
|
NPTN
3269
DELISTED
NEOPHOTONICS CORP
NPTN
| $523K | ﹤0.01% |
58,938
+16,197
| +38% | +$140K |
|
3270
Adtran
ADTN
$616M
| $521K | ﹤0.01% |
47,633
-3,447
| -7% | -$35.6K |
|
3271
CALL
Crown Holdings
CCK
$13.1B
| $521K | ﹤0.01% |
8,000
-7,500
| -48% | -$472K |
|
|
LVOX
3272
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
| $520K | ﹤0.01% |
+49,700
| New | +$501K |
|
3273
Qfin Holdings
QFIN
$1.61B
| $519K | ﹤0.01% |
+48,500
| New | +$442K |
|
|
SFIX
3274
PUT
Stitch Fix
SFIX
$560M
| $519K | ﹤0.01% |
20,800
-38,200
| -65% | -$754K |
|
3275
RE/MAX Holdings
RMAX
$242M
| $518K | ﹤0.01% |
16,483
+1,718
| +12% | +$45.6K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.